Interactions of intravenous anaesthetics with cerebral α2- adrenoceptors;Interaktionen intravenoser anasthetika mit zerebralen α2- adrenozeptoren

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 34, Issue 10, 1999, Pages 642-647

  Scholz, Jens ^a   Tonner, P H ^a   Krause, T ^a   Paris, Andrea ^a   Steinfath, M ^a   Wappler, F ^a   Von Knobelsdorff, G ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Alpha2 adrenoceptors; Anaesthetic mechanisms of action; Ketamine; Propofol; Sedation

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; CLONIDINE; ETOMIDATE; INTRAVENOUS ANESTHETIC AGENT; IODINE 125; KETAMINE; PROPOFOL; 4 IODOCLONIDINE; 4-IODOCLONIDINE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANESTHETIC AGENT; DRUG DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DRUG BINDING; DRUG MECHANISM; INTRAVENOUS ANESTHESIA; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; RAT; SEDATION; AFFINITY LABELING; ANIMAL; AUTORADIOGRAPHY; BINDING COMPETITION; BRAIN; DRUG EFFECT; IN VITRO STUDY; METABOLISM; WISTAR RAT;

ADRENERGIC ALPHA-AGONISTS; AFFINITY LABELS; ANESTHETICS, DISSOCIATIVE; ANESTHETICS, INTRAVENOUS; ANIMALS; AUTORADIOGRAPHY; BINDING, COMPETITIVE; BRAIN; CLONIDINE; KETAMINE; PROPOFOL; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 0033210470     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-1999-219     Document Type: Article

References (36)

1. Scholz J, Tonner PH, Krause T, Twisselmann H, Schulte am Esch J: Interaction of etomidate with alpha2-adrenergic receptors of rat brain tissue. Anesthesiology 1997; 87: A635
2. Tonner PH, Scholz J: Clinical perspectives of alpha2-adrenoceptor agonists. Curr Opin Anaesth 1996; 9: 471-480
3. Scheinin M, Lomasney JW, Hayden-Hixson DM, Schambra UB, Caron MG, Lefkowitz RJ, Fremeau RT, Jr.: Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain. Brain Res Mol Brain Res 1994; 21: 133-149
4. Tonner PH, Scholz J: Das NO/cGMP-Signaltransduktionssystem: Ein zentraler Angriffspunkt von Anästhetika. Anästhesiol Intensivmed Notfallmed Schmerzther 1999; 34: 78-89
5. Tonner PH, Poppers DM, Miller KW: The general anesthetic potency of propofol and its dependence on hydrostatic pressure. Anesthesiology 1992; 77: 926-931
6. Overton CE: Studien über die Narkose, zugleich ein Beitrag zur allgemeinen Pharmakologie. Anesthesiology Aufl. G. Fischer Verlag Jena 1901
7. Violet JM, Downie DL, Nakisa RC, Lieb WR, Franks NP: Differential sensitivities of mammalian neuronal and muscle nicotinic acetylcholine receptors to general anesthetics. Anesthesiology 1997; 86: 866-874
8. Flood P, Ramirez-Latorre J, Role L: Alpha 4 beta 2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but alpha 7-type nicotinic acetylcholine receptors are unaffected. Anesthesiology 1997; 86: 859-865
9. Mascia MP, Machu TK, Harris RA: Enhancement of homomeric glycine receptor function by long-chain alcohols and anaesthetics. Br J Pharmacol 1996; 119: 1331-1336
10. Bickler PE, Buck LT, Feiner JR: Volatile and intravenous anesthetics decrease glutamate release from cortical brain slices during anoxia. Anesthesiology 1995; 83: 1233-1240
11. Frenkel C, Duch DS, Urban BW: Effects of i.v. anaesthetics on human brain sodium channels. Br J Anaesth 1993; 71: 15-24
12. Concas A, Santoro G, Mascia MP, Serra M, Sanna E, Biggio G: The general anesthetic propofol enhances the function of gammaaminobutyric acid coupled chloride channel in the rat cerebral cortex. J Neurochem 1990; 55: 2135-2138
13. Irifune M, Shimizu T, Nomoto M, Fukuda T: Ketamine induced anesthesia involves the N-methyl-D-aspartate receptor channel complex. Brain Res 1992; 596: 1-9
14. Flohr H, Glade U, Motzko D: The role of the NMDA synapse in general anesthesia. Toxicol Lett 1998; 100-101: 23-30
15. Orser BA, Pennefather PS, MacDonald JF: Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors. Anesthesiology 1997; 86: 903-917
16. Kress HG: Wirkmechanismen von Ketamin. Anaesthesist 1997; 46: S8-S19
17. Bass A: Über eine Wirkung des Adrenalins auf das Gehirn. Z Ges Neurol Psychiat 1914; 26: 600-601
18. Bylund DB, U'Pritchard DC: Characterization of alpha-1 and alpha-2 adrenergic recceptors. Int Rev Biol 1983; 24: 343-431
19. Doze VA, Chen B, Maze M: Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha2-adrenergic receptor. Anesthesiology 1989; 69: 819-823
20. Pittalug A, Raiteri Mntirhpa-arGrNL-, 1987: GABAergic nerve terminals in rat hippocampus possess alpha2-adrenoceptors regulating GABA release. Neurosci Lett 1987; 76: 363-367
21. Mueller AL, Dunwiddie TV: Anticonvulsant and proconvulsant actions of alpha-and beta-noradrenergic agonists on epileptiform activity in rat hippocampus in vitro. Epilepsia 1983; 24: 46-57
22. Aantaa R, Marjamaeki A, Scheinin M: Molecular pharmacology of alpha 2-adrenoceptor subtypes. Ann Med 1995; 27: 439-449
23. Hayashi H, Maze M: Alpha 2 adrenoceptor agonists and anaesthesia. Br J Anaesth 1993; 71: 108-118
24. Maze M, Virtanen R, Daunt D, Banks SJ, Stover EP, Feldman D: Effects of dexmedetomidine, a novel imidazole sedative-anesthetic agent, on adrenal steroidogenesis: in vivo and in vitro studies. Anesth Analg 1991; 73: 204-208
25. Segal IS, Vickery RG, Walton JK, Doze VA, Maze M: Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha 2 adrenergic receptor. Anesthesiology 1988; 69: 818-823
26. Vickery RG, Sheridan BC, Segal IS, Maze M: Anesthetic and hemodynamic effects of the stereoisomers of medetomidine, an alpha 2-adrenergic agonist, in halothane-anesthetized dogs. Anesth Analg 1988; 67: 611-615
27. Carabine UA, Milligan KR, Moore JA: Adrenergic modulation of preoperative anxiety: a comparison of temazepam, clonidine, and timolol. Anesth Analg 1991; 73: 633-637
28. Wright RMC, Carabine UA, Orr DA, McClune S, Moore J: Preanaesthetic medication with clonidine. Br J Anaesth 1990; 65: 628-635
29. Fielding S, Wilker J, Hynes M, Szewczak M, Novick WJ, Lal H: A comparison of clonidine with morphine for antinociceptive and anti-withdrawal actions. J Pharmacol Exp Ther 1978; 207: 899-905
30. Stevens CW, Monasky MS, Yaksh TL: Spinal infusion of opiate and alpha-2 agonists in rats: Tolerance and cross-tolerance studies. J Pharmacol Exp Ther 1988; 244: 63-70
31. Asthon H: Benzodiazepine withdrawal: Outcome in 50 patients. Br J Addict 1987; 82: 665-671
32. Cushman P, Sowers JR: Alcohol withdrawal: clinical and hormonal responses to alpha2-adrenergic treatment. Alcoholism 1989; 13: 361-364
33. Yam PC, Forbes A, Kox WJ: Clonidine in the treatment of alcohol withdrawal in the intensive care unit. Br J Anaesth 1992; 68: 106-108
34. Scholz J, Bause H, Reymann A, Duerig M: Zur Behandlung mit Clonidin bei kurzdarmsyndrombedingter therapierefraktärer Diarrhoe. Anästhesiol Intensivmed Notfallmed Schmerzther 1991; 26: 265-269
35. Maier C, Steinberg GK, Sun GH, Zhi GT, Maze M: Neuroprotection by the alpha 2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia. Anesthesiology 1993; 79: 306-312
36. Hoffman WE, Kochs E, Werner C, Thomas C, Albrecht RF: Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole. Anesthesiology 1991; 75: 328-332